Hothorn L
Department of Biostatistics, German Cancer Research Center, Heidelberg.
Environ Health Perspect. 1994 Jan;102 Suppl 1(Suppl 1):121-5. doi: 10.1289/ehp.94102s1121.
The in vivo micronucleus assay can be analyzed by comparing the number of micronuclei (MN) of several dose groups with those of a control group. In several publications, difficulties arose in estimating a suitable distribution for MN, even in the untreated historical control groups. Mitchell et al. described the presence of a subpopulation of more susceptible responders. Based on this assumption of such a subpopulation, score tests were used for the mixing distribution of responders and nonresponders (behavior same as in untreated control animals) within the dose groups. The power behavior of these tests was characterized with a simulation study. The advantage of score tests can be shown, even in the practical and important guideline case of only five animals per group.
体内微核试验可通过比较几个剂量组的微核(MN)数量与对照组的微核数量来进行分析。在一些出版物中,即使在未处理的历史对照组中,估计MN的合适分布也存在困难。米切尔等人描述了存在一个更易反应的亚群。基于这种亚群的假设,得分检验用于剂量组内反应者和无反应者(行为与未处理的对照动物相同)的混合分布。这些检验的功效行为通过模拟研究进行了表征。即使在每组仅五只动物这种实际且重要的指南案例中,也能显示得分检验的优势。